Foresee Pharmaceuticals Co Ltd (6576) — Capital Reinvestment Ratio

Latest as of June 2022: 0.00x

Foresee Pharmaceuticals Co Ltd (6576) has a Capital Reinvestment Ratio of 0.00x as of June 2022, meaning it reinvests 0% of its operating cash flow (NT$143.03 Million) in capital expenditures (NT$590.00K). Check Foresee Pharmaceuticals Co Ltd (6576) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

NT$143.03 Million

TWD

Capital Expenditures

NT$590.00K

TWD

Data as of

Jun 2022

Most recent filing

Annual Capital Reinvestment Ratio for Foresee Pharmaceuticals Co Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Foresee Pharmaceuticals Co Ltd from None to None. See Foresee Pharmaceuticals Co Ltd (6576) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (TWD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow